194 related articles for article (PubMed ID: 36722045)
1. NDUFA4L2 reduces mitochondrial respiration resulting in defective lysosomal trafficking in clear cell renal cell carcinoma.
Kubala JM; Laursen KB; Schreiner R; Williams RM; van der Mijn JC; Crowley MJ; Mongan NP; Nanus DM; Heller DA; Gudas LJ
Cancer Biol Ther; 2023 Dec; 24(1):2170669. PubMed ID: 36722045
[TBL] [Abstract][Full Text] [Related]
2. Role of NADH Dehydrogenase (Ubiquinone) 1 Alpha Subcomplex 4-Like 2 in Clear Cell Renal Cell Carcinoma.
Minton DR; Fu L; Mongan NP; Shevchuk MM; Nanus DM; Gudas LJ
Clin Cancer Res; 2016 Jun; 22(11):2791-801. PubMed ID: 26783287
[TBL] [Abstract][Full Text] [Related]
3. Integrated multi-omics characterization reveals a distinctive metabolic signature and the role of NDUFA4L2 in promoting angiogenesis, chemoresistance, and mitochondrial dysfunction in clear cell renal cell carcinoma.
Lucarelli G; Rutigliano M; Sallustio F; Ribatti D; Giglio A; Lepore Signorile M; Grossi V; Sanese P; Napoli A; Maiorano E; Bianchi C; Perego RA; Ferro M; Ranieri E; Serino G; Bell LN; Ditonno P; Simone C; Battaglia M
Aging (Albany NY); 2018 Dec; 10(12):3957-3985. PubMed ID: 30538212
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial Ndufa4l2 Enhances Deposition of Lipids and Expression of Ca9 in the TRACK Model of Early Clear Cell Renal Cell Carcinoma.
Laursen KB; Chen Q; Khani F; Attarwala N; Gross SS; Dow L; Nanus DM; Gudas LJ
Front Oncol; 2021; 11():783856. PubMed ID: 34970493
[TBL] [Abstract][Full Text] [Related]
5. HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells.
Teng R; Liu Z; Tang H; Zhang W; Chen Y; Xu R; Chen L; Song J; Liu X; Deng H
Redox Biol; 2019 Jun; 24():101218. PubMed ID: 31112866
[TBL] [Abstract][Full Text] [Related]
6. NDUFA4L2 expression predicts poor prognosis in clear cell renal cell carcinoma patients.
Liu L; Lan G; Peng L; Xie X; Peng F; Yu S; Wang Y; Tang X
Ren Fail; 2016 Sep; 38(8):1199-205. PubMed ID: 27453328
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial NDUFA4L2 is a novel regulator of skeletal muscle mass and force.
Liu Z; Chaillou T; Santos Alves E; Mader T; Jude B; Ferreira DMS; Hynynen H; Cheng AJ; Jonsson WO; Pironti G; Andersson DC; Kenne E; Ruas JL; Tavi P; Lanner JT
FASEB J; 2021 Dec; 35(12):e22010. PubMed ID: 34724256
[TBL] [Abstract][Full Text] [Related]
8. Induction of the mitochondrial NDUFA4L2 protein by HIF-1α decreases oxygen consumption by inhibiting Complex I activity.
Tello D; Balsa E; Acosta-Iborra B; Fuertes-Yebra E; Elorza A; Ordóñez Á; Corral-Escariz M; Soro I; López-Bernardo E; Perales-Clemente E; Martínez-Ruiz A; Enríquez JA; Aragonés J; Cadenas S; Landázuri MO
Cell Metab; 2011 Dec; 14(6):768-79. PubMed ID: 22100406
[TBL] [Abstract][Full Text] [Related]
9. NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1.
Wang L; Peng Z; Wang K; Qi Y; Yang Y; Zhang Y; An X; Luo S; Zheng J
PeerJ; 2017; 5():e4065. PubMed ID: 29158991
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial NDUFA4L2 protein promotes the vitality of lung cancer cells by repressing oxidative stress.
Meng L; Yang X; Xie X; Wang M
Thorac Cancer; 2019 Apr; 10(4):676-685. PubMed ID: 30710412
[TBL] [Abstract][Full Text] [Related]
11. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional and metabolic remodeling in clear cell renal cell carcinoma caused by ATF4 activation and the integrated stress response (ISR).
van der Mijn JC; Chen Q; Laursen KB; Khani F; Wang X; Dorsaint P; Sboner A; Gross SS; Nanus DM; Gudas LJ
Mol Carcinog; 2022 Sep; 61(9):851-864. PubMed ID: 35726553
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of NDUFA4L2 is associated with poor prognosis in patients with colorectal cancer.
Lv Y; Nie SL; Zhou JM; Liu F; Hu YB; Jiang JR; Li N; Liu JS
ANZ J Surg; 2017 Dec; 87(12):E251-E255. PubMed ID: 27226356
[TBL] [Abstract][Full Text] [Related]
14. NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma.
Lai RK; Xu IM; Chiu DK; Tse AP; Wei LL; Law CT; Lee D; Wong CM; Wong MP; Ng IO; Wong CC
Clin Cancer Res; 2016 Jun; 22(12):3105-17. PubMed ID: 26819450
[TBL] [Abstract][Full Text] [Related]
15. NDUFA4L2 in smooth muscle promotes vascular remodeling in hypoxic pulmonary arterial hypertension.
Liu Y; Nie X; Zhu J; Wang T; Li Y; Wang Q; Sun Z
J Cell Mol Med; 2021 Jan; 25(2):1221-1237. PubMed ID: 33340241
[TBL] [Abstract][Full Text] [Related]
16. Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate.
Nilsson H; Lindgren D; Mandahl Forsberg A; Mulder H; Axelson H; Johansson ME
Cell Death Dis; 2015 Jan; 6(1):e1585. PubMed ID: 25569102
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic targeting of P2X4 receptor and mitochondrial metabolism in clear cell renal carcinoma models.
Rupert C; Dell' Aversana C; Mosca L; Montanaro V; Arcaniolo D; De Sio M; Bilancio A; Altucci L; Palinski W; Pili R; de Nigris F
J Exp Clin Cancer Res; 2023 May; 42(1):134. PubMed ID: 37231503
[TBL] [Abstract][Full Text] [Related]
18. UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells.
Luo Y; Medina Bengtsson L; Wang X; Huang T; Liu G; Murphy S; Wang C; Koren J; Schafer Z; Lu X
Sci Rep; 2020 Sep; 10(1):15021. PubMed ID: 32929120
[TBL] [Abstract][Full Text] [Related]
19. NDUFA4L2 protects against ischaemia/reperfusion-induced cardiomyocyte apoptosis and mitochondrial dysfunction by inhibiting complex I.
Li J; Bai C; Guo J; Liang W; Long J
Clin Exp Pharmacol Physiol; 2017 Jul; 44(7):779-786. PubMed ID: 28429857
[TBL] [Abstract][Full Text] [Related]
20. A transgenic mouse expressing miR-210 in proximal tubule cells shows mitochondrial alteration: possible association of miR-210 with a shift in energy metabolism.
Nakada C; Hijiya N; Tsukamoto Y; Yano S; Kai T; Uchida T; Kimoto M; Takahashi M; Daa T; Matsuura K; Shin T; Mimata H; Moriyama M
J Pathol; 2020 May; 251(1):12-25. PubMed ID: 32073141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
